ICU Medical (NASDAQ: ICUI) reported Q3 EPS of $1.90, $0.59 better than the analyst estimate of $1.31. Revenue for the quarter came in at $318.6 million versus the consensus estimate of $284.7 million.

GUIDANCE:

ICU Medical sees FY2020 EPS of $6.65-$7.00, versus the consensus of $6.40.

• The Company is narrowing its 2020 outlook for adjusted EBITDA from a range of $230 million to $250 million to a range of $235 million to $245 million and updating adjusted earnings per share from a range of $5.95 to $6.65 to a range of $6.65 to $7.00

For earnings history and earnings-related data on ICU Medical (ICUI) click here.